OBJECTIVE: The use of patient reported outcomes (PRO) in routine clinical practice is becoming increasingly common, but there is limited knowledge about the development and implementation of PRO. The objective of the current paper is to provide a thorough description of the development and implementation of a PRO on health related quality of life (HRQOL)--the QLIC-ON PROfile--in clinical paediatric oncology practice. METHODS: The development of the QLIC-ON PROfile is explained by elucidating important choices: the HRQOL instrument, the professional that uses the QLIC-ON PROfile, the optimal form of HRQOL feedback and whether or not a clinically important difference is reported. The description of the implementation of the QLIC-ON PROfile focuses on the education and commitment of the professional that uses the QLIC-ON PROfile. Study design and outcome measures are also elaborated on. RESULTS: Important considerations regarding the development and implementation of PRO interventions are reported. These considerations have also resulted in educational material. CONCLUSION: Our study adds to current knowledge of PRO research. This paper can be used as a practical guide for researchers and other professionals, who are interested in setting up PRO interventions in any clinical setting.
OBJECTIVE: The use of patient reported outcomes (PRO) in routine clinical practice is becoming increasingly common, but there is limited knowledge about the development and implementation of PRO. The objective of the current paper is to provide a thorough description of the development and implementation of a PRO on health related quality of life (HRQOL)--the QLIC-ON PROfile--in clinical paediatric oncology practice. METHODS: The development of the QLIC-ON PROfile is explained by elucidating important choices: the HRQOL instrument, the professional that uses the QLIC-ON PROfile, the optimal form of HRQOL feedback and whether or not a clinically important difference is reported. The description of the implementation of the QLIC-ON PROfile focuses on the education and commitment of the professional that uses the QLIC-ON PROfile. Study design and outcome measures are also elaborated on. RESULTS: Important considerations regarding the development and implementation of PRO interventions are reported. These considerations have also resulted in educational material. CONCLUSION: Our study adds to current knowledge of PRO research. This paper can be used as a practical guide for researchers and other professionals, who are interested in setting up PRO interventions in any clinical setting.
Authors: Joanne Wolfe; Liliana Orellana; E Francis Cook; Christina Ullrich; Tammy Kang; Jeffrey Russell Geyer; Chris Feudtner; Jane C Weeks; Veronica Dussel Journal: J Clin Oncol Date: 2014-03-10 Impact factor: 44.544
Authors: Lotte Haverman; Vivian Engelen; Marion A J van Rossum; Hugo S A Heymans; Martha A Grootenhuis Journal: BMC Pediatr Date: 2011-01-12 Impact factor: 2.125
Authors: Elizabeth D Cox; Sarah K Dobrozsi; Christopher B Forrest; Wendy E Gerhardt; Harald Kliems; Bryce B Reeve; Nan E Rothrock; Jin-Shei Lai; Jacob M Svenson; Lindsay A Thompson; Thuy Dan N Tran; Carole A Tucker Journal: J Pediatr Date: 2020-11-30 Impact factor: 4.406
Authors: Maria J Santana; Lotte Haverman; Kate Absolom; Elena Takeuchi; David Feeny; Martha Grootenhuis; Galina Velikova Journal: Qual Life Res Date: 2015-01-15 Impact factor: 4.147
Authors: Bernhard Holzner; Johannes M Giesinger; Jakob Pinggera; Stefan Zugal; Felix Schöpf; Anne S Oberguggenberger; Eva M Gamper; August Zabernigg; Barbara Weber; Gerhard Rumpold Journal: BMC Med Inform Decis Mak Date: 2012-11-09 Impact factor: 2.796
Authors: Michael R Robling; David K Ingledew; Giles Greene; Adrian Sayers; Chris Shaw; Lesley Sander; Ian T Russell; John G Williams; Kerenza Hood Journal: BMC Health Serv Res Date: 2010-06-24 Impact factor: 2.655
Authors: Emily R Haines; M Alexis Kirk; Lauren Lux; Andrew B Smitherman; Byron J Powell; Alex Dopp; Angela M Stover; Sarah A Birken Journal: Transl Behav Med Date: 2022-01-18 Impact factor: 3.626
Authors: Nuray A McNeill; Wijnanda A Kors; Machteld I Bosscha; Jennifer van Dijk; Armida W M Fabius; Ton Houffelaar; Irma M Verdonck-de Leeuw; Annette C Moll Journal: J Cancer Surviv Date: 2017-09-25 Impact factor: 4.442